Innogen  ·  Publications  ·  Reports
Consequences, Opportunities and Challenges of Modern Biotechnology for Europe (Bio4EU)

Zika, E   Papatryfon, I   Wolf, O   Gomez-Barbero, M   Stein, AJ   Bock, A

April 2007

Institute for Prospective Technological Studies (IPTS), European Commission

Open / download PDF, 5.7MB

Research at Innogen: Consequences, Opportunities and Challenges of Modern Biotech ...

This report was commissioned and published by the Institute for Prospective Technological Studies (IPTS) at the Joint Research Centre (JRC) of the European Commission.

Biotechnology is often considered to be one of the key technologies that will help enable the long-term sustainable development of the European Union (EU), particularly in terms of economic growth, environmental protection and public health.

However, despite the high levels of research funding, both public and private, and the high expectations, especially regarding biotechnology-enabled medical advances, there has been a lack of reliable information on the contribution that biotechnology is really making and on its economic, social and environmental consequences.

The 'Bio4EU' study was established in response to a request from the European Parliament in the context of the EU's Lisbon Strategy and Sustainable Development Strategy.

The study was conducted between autumn 2005 and spring 2007 under the leadership of the European Commission's Joint Research Centre. It focused on current applications of modern biotechnology in its three main fields:

  • Medicine and Health Care
  • Primary Production and Agro-Food
  • Industrial Production Processes, Energy and the Environment

Innogen's contribution to this report included mapping the adoption of modern biotechnology in primary production/agro-food in the EU and evaluating the consequences, opportunities and challenges of applications in primary production and agro-food.

This report, IPTS/JRC website